Astellas Pharma (4503.T) Financial Statements
Price: $1341
Market Cap: $2.40T
Avg Volume: 6.64M
Market Cap: $2.40T
Avg Volume: 6.64M
Country: JP
Industry: Drug Manufacturers - General
Sector: Healthcare
Industry: Drug Manufacturers - General
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Astellas Pharma.
Income Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.60T | $1.52T | $1.30T | $1.25T | $1.30T | $1.31T | $1.30T | $1.31T | $1.37T | $1.25T |
| Cost of Revenue | $292.49B | $288.35B | $253.01B | $246.06B | $276.74B | $292.05B | $294.25B | $320.50B | $335.60B | $333.20B |
| Gross Profit | $1.31T | $1.23T | $1.04T | $1.00T | $1.02T | $1.01T | $1.01T | $991.16B | $1.04T | $914.06B |
| Gross Profit Ratio | 81.76% | 81.01% | 80.48% | 80.31% | 78.73% | 77.64% | 77.37% | 75.57% | 75.55% | 73.29% |
| Research and Development Expenses | $294.19B | $276.13B | $246.01B | $224.49B | $224.23B | $208.68B | $220.78B | $208.13B | $225.66B | $206.59B |
| General and Administrative Expenses | $740.11B | $630.27B | $548.84B | $504.32B | $499.30B | $490.26B | $478.33B | $470.78B | $500.36B | $452.52B |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $740.11B | $630.27B | $548.84B | $504.32B | $499.30B | $490.26B | $478.33B | $470.78B | $500.36B | $452.52B |
| Other Expenses | $251.37B | $- | $117.34B | $139.09B | $54.93B | $69.81B | $91.28B | $49.56B | $60.86B | $69.50B |
| Operating Expenses | $1.29T | $1.10T | $912.19B | $867.89B | $778.45B | $768.76B | $790.39B | $728.47B | $786.88B | $728.62B |
| Cost and Expenses | $1.43T | $1.39T | $1.17T | $1.11T | $1.06T | $1.06T | $1.08T | $1.05T | $1.12T | $1.06T |
| Interest Income | $11.46B | $8.11B | $6.15B | $11.61B | $4.36B | $6.36B | $6.64B | $22.92B | $14.41B | $7.10B |
| Interest Expense | $9.37B | $8.78B | $4.95B | $2.33B | $3.00B | $1.30B | $1.78B | $1.98B | $1.63B | $3.08B |
| Depreciation and Amortization | $157.84B | $105.74B | $79.68B | $72.65B | $66.40B | $63.46B | $64.86B | $63.79B | $69.19B | $65.47B |
| EBITDA | $195.34B | $240.46B | $241.03B | $219.83B | $316.41B | $313.73B | $284.28B | $346.90B | $332.21B | $255.62B |
| EBITDA Ratio | 12.18% | 15.83% | 18.60% | 17.59% | 24.32% | 24.02% | 21.86% | 26.45% | 24.20% | 20.49% |
| Operating Income | $124.61B | $133.03B | $155.69B | $136.05B | $243.99B | $243.91B | $213.26B | $260.83B | $248.99B | $185.66B |
| Operating Income Ratio | 7.77% | 8.76% | 12.01% | 10.89% | 18.76% | 18.67% | 16.40% | 19.89% | 18.14% | 14.89% |
| Total Other Income Expenses Net | $-99.64B | $-668.00M | $1.20B | $8.79B | $1.36B | $5.05B | $4.86B | $20.94B | $-7.73B | $4.02B |
| Income Before Tax | $24.97B | $132.36B | $156.89B | $145.32B | $245.35B | $248.97B | $218.11B | $281.77B | $261.77B | $189.68B |
| Income Before Tax Ratio | 1.56% | 8.72% | 12.10% | 11.63% | 18.86% | 19.06% | 16.77% | 21.48% | 19.07% | 15.21% |
| Income Tax Expense | $7.92B | $33.65B | $32.80B | $24.73B | $49.94B | $26.70B | $53.43B | $63.07B | $68.08B | $53.83B |
| Net Income | $17.05B | $98.71B | $124.09B | $120.59B | $195.41B | $222.26B | $164.68B | $218.70B | $193.69B | $135.86B |
| Net Income Ratio | 1.06% | 6.50% | 9.57% | 9.65% | 15.02% | 17.01% | 12.66% | 16.67% | 14.11% | 10.89% |
| EPS | $9.50 | $54.24 | $67.08 | $64.93 | $104.15 | $115.05 | $81.11 | $103.69 | $89.75 | $61.50 |
| EPS Diluted | $9.47 | $54.09 | $67.05 | $64.90 | $104.08 | $114.94 | $81.02 | $103.55 | $89.62 | $61.40 |
| Weighted Average Shares Outstanding | 1.79B | 1.82B | 1.85B | 1.86B | 1.88B | 1.93B | 2.03B | 2.11B | 2.16B | 2.21B |
| Weighted Average Shares Outstanding Diluted | 1.80B | 1.83B | 1.85B | 1.86B | 1.88B | 1.93B | 2.03B | 2.11B | 2.16B | 2.21B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $335.69B | $376.84B | $315.99B | $326.13B | $318.39B | $311.07B | $331.73B | $340.92B | $360.03B | $396.43B |
| Short Term Investments | $- | $19.78B | $21.30B | $5.56B | $9.46B | $2.61B | $13.52B | $13.55B | $14.39B | $59.91B |
| Cash and Short Term Investments | $335.69B | $396.62B | $337.28B | $331.69B | $327.85B | $313.68B | $345.25B | $354.48B | $374.42B | $456.34B |
| Net Receivables | $548.04B | $427.96B | $382.46B | $343.18B | $347.04B | $342.63B | $319.51B | $309.82B | $327.60B | $332.92B |
| Inventory | $248.74B | $174.39B | $153.07B | $164.08B | $151.02B | $151.51B | $147.63B | $182.54B | $161.69B | $156.91B |
| Other Current Assets | $62.27B | $50.98B | $50.54B | $33.64B | $41.60B | $49.34B | $33.23B | $29.83B | $33.82B | $19.79B |
| Total Current Assets | $1.19T | $1.05T | $923.35B | $872.59B | $867.51B | $857.16B | $845.62B | $876.66B | $897.54B | $965.96B |
| Property Plant Equipment Net | $293.74B | $286.46B | $269.04B | $264.62B | $268.60B | $173.48B | $181.29B | $191.12B | $200.96B | $202.87B |
| Goodwill | $418.69B | $328.41B | $303.03B | $284.01B | $267.51B | $225.86B | $212.98B | $175.35B | $150.66B | $136.34B |
| Intangible Assets | $1.45T | $562.50B | $623.43B | $651.43B | $738.51B | $429.71B | $416.91B | $387.42B | $339.20B | $295.84B |
| Goodwill and Intangible Assets | $1.87T | $890.91B | $926.46B | $935.44B | $1.01T | $655.57B | $629.89B | $562.77B | $489.86B | $432.18B |
| Long Term Investments | $144.42B | $145.03B | $141.21B | $146.80B | $123.15B | $118.48B | $57.00B | $51.03B | $77.47B | $52.19B |
| Tax Assets | $45.59B | $84.17B | $72.33B | $54.18B | $52.88B | $92.96B | $97.24B | $90.35B | $80.25B | $51.20B |
| Other Non-Current Assets | $18.60B | $1.00M | $-1.00M | $-1.00M | $-1.00M | $-2.00M | $47.17B | $48.97B | $53.27B | $89.18B |
| Total Non-Current Assets | $2.37T | $1.41T | $1.41T | $1.40T | $1.45T | $1.04T | $1.01T | $944.24B | $901.80B | $827.62B |
| Other Assets | $- | $- | $- | $- | $- | $- | $-1.00M | $1.00M | $- | $-1.00M |
| Total Assets | $3.57T | $2.46T | $2.33T | $2.27T | $2.32T | $1.90T | $1.86T | $1.82T | $1.80T | $1.79T |
| Account Payables | $185.19B | $140.24B | $130.74B | $124.78B | $171.95B | $185.28B | $140.91B | $182.83B | $181.56B | $226.60B |
| Short Term Debt | $472.28B | $75.00B | $- | $- | $344.11B | $- | $- | $- | $- | $- |
| Tax Payables | $38.52B | $5.14B | $32.39B | $8.39B | $4.01B | $17.59B | $25.18B | $10.90B | $19.31B | $14.12B |
| Deferred Revenue | $- | $-88.55B | $-157.73B | $-136.10B | $11.70B | $13.32B | $60.03B | $58.90B | $28.78B | $- |
| Other Current Liabilities | $589.74B | $505.66B | $524.28B | $459.20B | $266.94B | $281.48B | $195.50B | $147.23B | $183.71B | $180.16B |
| Total Current Liabilities | $1.29T | $726.03B | $687.41B | $592.37B | $798.71B | $497.67B | $421.62B | $399.86B | $413.36B | $420.89B |
| Long Term Debt | $518.49B | $-9.82B | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue Non-Current | $- | $121.28B | $138.94B | $163.80B | $173.48B | $98.46B | $22.30B | $34.15B | $61.69B | $-716.00M |
| Deferred Tax Liabilities Non-Current | $51.35B | $6.05B | $5.82B | $18.16B | $27.66B | $5.17B | $26.43B | $25.34B | $-64.01B | $38.00M |
| Other Non-Current Liabilities | $118.05B | $45.20B | $39.91B | $113.18B | $56.80B | $125.01B | $119.57B | $115.08B | $65.08B | $54.73B |
| Total Non-Current Liabilities | $687.89B | $222.53B | $184.68B | $295.14B | $230.28B | $141.59B | $168.30B | $149.24B | $126.77B | $54.77B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $1.97T | $948.56B | $872.09B | $887.51B | $1.03T | $639.25B | $589.92B | $549.09B | $540.13B | $475.66B |
| Preferred Stock | $- | $1.17T | $1.21T | $1.22T | $1.18T | $1.11T | $- | $- | $- | $- |
| Common Stock | $103.00B | $103.00B | $103.00B | $103.00B | $103.00B | $103.00B | $103.00B | $103.00B | $103.00B | $103.00B |
| Retained Earnings | $809.40B | $908.16B | $944.26B | $953.29B | $905.85B | $991.96B | $976.08B | $1.01T | $973.05B | $905.08B |
| Accumulated Other Comprehensive Income Loss | $533.30B | $340.64B | $247.51B | $167.37B | $109.99B | $150.77B | $147.94B | $116.00B | $163.36B | $220.01B |
| Other Total Stockholders Equity | $150.29B | $156.16B | $165.53B | $162.45B | $170.33B | $12.67B | $41.27B | $38.88B | $19.79B | $89.83B |
| Total Stockholders Equity | $1.60T | $1.51T | $1.46T | $1.39T | $1.29T | $1.26T | $1.27T | $1.27T | $1.26T | $1.32T |
| Total Equity | $1.60T | $1.51T | $1.46T | $1.39T | $1.29T | $1.26T | $1.27T | $1.27T | $1.26T | $1.32T |
| Total Liabilities and Stockholders Equity | $3.57T | $2.46T | $2.33T | $2.27T | $2.32T | $1.90T | $1.86T | $1.82T | $1.80T | $1.79T |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $3.57T | $2.46T | $2.33T | $2.27T | $2.32T | $1.90T | $1.86T | $1.82T | $1.80T | $1.79T |
| Total Investments | $144.42B | $110.58B | $101.88B | $102.97B | $78.96B | $85.11B | $70.51B | $64.58B | $91.86B | $112.10B |
| Total Debt | $1.01T | $200.01B | $212.74B | $278.26B | $413.33B | $1.20B | $1.35B | $1.64B | $1.23B | $716.00M |
| Net Debt | $670.03B | $-176.83B | $-103.24B | $-47.86B | $94.94B | $-309.88B | $-330.38B | $-339.29B | $-358.80B | $-395.71B |
Cash Flow Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $17.05B | $132.36B | $156.89B | $145.32B | $245.35B | $248.97B | $218.11B | $281.77B | $261.77B | $189.68B |
| Depreciation and Amortization | $157.84B | $105.74B | $79.68B | $72.65B | $66.40B | $63.46B | $64.86B | $63.79B | $69.19B | $65.47B |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Change in Working Capital | $-51.70B | $-24.21B | $5.96B | $-31.73B | $-43.79B | $9.71B | $-12.61B | $-5.94B | $-59.91B | $17.52B |
| Accounts Receivables | $-55.95B | $-4.85B | $-8.00B | $22.16B | $-16.39B | $-25.64B | $-6.63B | $5.06B | $-15.65B | $3.91B |
| Inventory | $-60.04B | $-7.09B | $24.06B | $-2.32B | $-6.04B | $-5.48B | $37.83B | $-26.64B | $-11.87B | $-18.15B |
| Accounts Payables | $29.47B | $-12.27B | $-10.10B | $-51.57B | $-21.36B | $40.83B | $-43.80B | $15.65B | $-32.39B | $- |
| Other Working Capital | $34.82B | $98.19B | $-16.64B | $47.39B | $-10.40B | $20.00M | $-50.44B | $20.71B | $-48.04B | $35.67B |
| Other Non Cash Items | $49.29B | $113.88B | $14.92B | $120.59B | $-45.96B | $-63.50B | $42.25B | $-104.01B | $42.69B | $-84.99B |
| Net Cash Provided by Operating Activities | $172.47B | $327.77B | $257.44B | $306.84B | $222.00B | $258.63B | $312.61B | $235.61B | $313.74B | $187.69B |
| Investments in Property Plant and Equipment | $-38.06B | $-88.54B | $-76.45B | $-77.44B | $-77.89B | $-52.13B | $-40.28B | $-48.65B | $-118.12B | $-81.17B |
| Acquisitions Net | $-784.97B | $- | $-670.00M | $-14.92B | $-320.76B | $-19.29B | $-83.72B | $-50.91B | $-42.65B | $-49.27B |
| Purchases of Investments | $- | $- | $-5.58B | $- | $- | $- | $-693.00M | $-484.00M | $-749.00M | $-3.58B |
| Sales Maturities of Investments | $- | $12.62B | $5.58B | $- | $- | $- | $6.97B | $28.64B | $16.75B | $9.74B |
| Other Investing Activities | $-22.77B | $-8.58B | $14.71B | $10.46B | $8.86B | $29.66B | $-4.07B | $-1.98B | $-2.28B | $52.80B |
| Net Cash Used for Investing Activities | $-845.80B | $-84.50B | $-62.41B | $-81.89B | $-389.79B | $-41.76B | $-121.80B | $-73.38B | $-147.05B | $-71.48B |
| Debt Repayment | $771.23B | $-15.00B | $-60.00B | $-126.00B | $326.00B | $- | $- | $- | $- | $- |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-10.73B | $-60.56B | $-50.72B | $-9.16B | $-52.90B | $-160.44B | $-130.71B | $-92.19B | $-120.13B | $-58.23B |
| Dividends Paid | $-116.65B | $-100.36B | $-85.24B | $-76.16B | $-73.54B | $-72.07B | $-71.63B | $-70.12B | $-69.61B | $-62.15B |
| Other Financing Activities | $-29.79B | $-19.71B | $-20.34B | $-18.16B | $-18.51B | $-1.17B | $-1.08B | $-3.84B | $-3.74B | $-743.00M |
| Net Cash Used Provided by Financing Activities | $614.06B | $-195.62B | $-216.30B | $-229.48B | $181.06B | $-233.68B | $-203.43B | $-166.15B | $-193.48B | $-121.12B |
| Effect of Forex Changes on Cash | $18.11B | $13.21B | $11.12B | $12.27B | $-5.94B | $-2.12B | $3.42B | $-15.18B | $-9.61B | $9.97B |
| Net Change in Cash | $-41.15B | $60.85B | $-10.14B | $7.74B | $7.32B | $-20.66B | $-9.19B | $-19.11B | $-36.40B | $5.06B |
| Cash at End of Period | $335.69B | $376.84B | $315.99B | $326.13B | $318.39B | $311.07B | $331.73B | $340.92B | $360.03B | $396.43B |
| Cash at Beginning of Period | $376.84B | $315.99B | $326.13B | $318.39B | $311.07B | $331.73B | $340.92B | $360.03B | $396.43B | $391.37B |
| Operating Cash Flow | $172.47B | $327.77B | $257.44B | $306.84B | $222.00B | $258.63B | $312.61B | $235.61B | $313.74B | $187.69B |
| Capital Expenditure | $-82.50B | $-88.54B | $-76.45B | $-77.44B | $-77.89B | $-52.13B | $-40.28B | $-48.65B | $-118.12B | $-81.17B |
| Free Cash Flow | $89.98B | $239.23B | $181.00B | $229.40B | $144.11B | $206.50B | $272.33B | $186.96B | $195.62B | $106.52B |